United Kingdom
United Kingdom

The 'go to' European specialist pharma company

Our business strategy

Peter Stein CEO
Peter Stein, CEO´╗┐´╗┐

 "Our vision is to be the 'go to' European specialist pharma company."

We provide expertise and 'know how' in Europe to develop, commercialise and manufacture products that offer real value to payers, healthcare professionals and patients.


We are a European company because this differentiates us. Our approach and adaptable infrastructure is integrated and focused upon ensuring that Norgine wins partnership opportunities for growth.

Our partnering capabilities are well recognised.  We partner in different ways and offer flexible structures to companies who need a partner in Europe that will meet their and our objectives


We have three clear strategic priorities:


1. Achieve double digit growth
2. Strengthen our late stage portfolio ( phase III onwards)
3. Be a dynamic place to work.



Peter Stein, CEO


" Norgine believes that there are attractive opportunities to develop innovative products which not only improve patient care but also can be proven to add economic value to the overall healthcare system."


"We are focused on identifying these opportunities and helping to bring them to market,"